DK158032C - Polydepotpraeparat med kontrolleret afgivelse af aktivt stof og fremgangsmaade til fremstilling af dette polydepotpraeparat - Google Patents

Polydepotpraeparat med kontrolleret afgivelse af aktivt stof og fremgangsmaade til fremstilling af dette polydepotpraeparat

Info

Publication number
DK158032C
DK158032C DK462685A DK462685A DK158032C DK 158032 C DK158032 C DK 158032C DK 462685 A DK462685 A DK 462685A DK 462685 A DK462685 A DK 462685A DK 158032 C DK158032 C DK 158032C
Authority
DK
Denmark
Prior art keywords
polydepot
preparation
preparing
procedure
active substance
Prior art date
Application number
DK462685A
Other languages
English (en)
Other versions
DK158032B (da
DK462685D0 (da
DK462685A (da
Inventor
Kim Kjoernaes
Finn Norring Christensen
Jens Rasmus Jensen
Original Assignee
Benzon As Alfred
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK62084A external-priority patent/DK62084D0/da
Priority claimed from DK0621/84A external-priority patent/DK62184D0/da
Application filed by Benzon As Alfred filed Critical Benzon As Alfred
Priority to DK462685A priority Critical patent/DK158032C/da
Publication of DK462685D0 publication Critical patent/DK462685D0/da
Publication of DK462685A publication Critical patent/DK462685A/da
Publication of DK158032B publication Critical patent/DK158032B/da
Application granted granted Critical
Publication of DK158032C publication Critical patent/DK158032C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
DK462685A 1984-02-10 1985-10-09 Polydepotpraeparat med kontrolleret afgivelse af aktivt stof og fremgangsmaade til fremstilling af dette polydepotpraeparat DK158032C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK462685A DK158032C (da) 1984-02-10 1985-10-09 Polydepotpraeparat med kontrolleret afgivelse af aktivt stof og fremgangsmaade til fremstilling af dette polydepotpraeparat

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
DK62084A DK62084D0 (da) 1984-02-10 1984-02-10 Diffusionsovertrukket polydepotpraeparat
DK0621/84A DK62184D0 (da) 1984-02-10 1984-02-10 Diffusionsovertrukket polydepotpraeparat
DK62184 1984-02-10
DK62084 1984-02-10
DK8500005 1985-02-08
PCT/DK1985/000005 WO1985003436A1 (en) 1984-02-10 1985-02-08 Diffusion coated multiple-units dosage form
DK462685A DK158032C (da) 1984-02-10 1985-10-09 Polydepotpraeparat med kontrolleret afgivelse af aktivt stof og fremgangsmaade til fremstilling af dette polydepotpraeparat
DK462685 1985-10-09

Publications (4)

Publication Number Publication Date
DK462685D0 DK462685D0 (da) 1985-10-09
DK462685A DK462685A (da) 1985-10-09
DK158032B DK158032B (da) 1990-03-19
DK158032C true DK158032C (da) 1990-08-13

Family

ID=26064325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK462685A DK158032C (da) 1984-02-10 1985-10-09 Polydepotpraeparat med kontrolleret afgivelse af aktivt stof og fremgangsmaade til fremstilling af dette polydepotpraeparat

Country Status (10)

Country Link
US (1) US4716041A (da)
EP (1) EP0153105B1 (da)
JP (1) JPH0759499B2 (da)
AU (1) AU571312B2 (da)
CA (1) CA1247009A (da)
DE (1) DE3586600T2 (da)
DK (1) DK158032C (da)
HK (1) HK1000201A1 (da)
IE (1) IE59287B1 (da)
WO (1) WO1985003436A1 (da)

Families Citing this family (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
EP0212745B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
JPS62114910A (ja) * 1985-11-13 1987-05-26 エラン　コ−ポレ−シヨン　ピ−　エル　シ− 吸収がコントロ−ルされた医薬製剤
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE3635522A1 (de) * 1986-10-18 1988-04-28 Euro Celtique Sa Pharmazeutische zusammensetzung
US4752470A (en) * 1986-11-24 1988-06-21 Mehta Atul M Controlled release indomethacin
SE460945B (sv) * 1987-01-15 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av furosemid
US5310572A (en) * 1987-02-03 1994-05-10 Dow Corning Corporation Process for forming a coated active agent-containing article
US4789546A (en) * 1987-02-19 1988-12-06 Consumer Products Corp. Multiple-layer tablet with contrasting organoleptic characteristics
US5288500A (en) * 1987-03-13 1994-02-22 Benzon Pharma A/S Oral composition containing particles comprising an active substance
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US4904477A (en) * 1987-07-08 1990-02-27 American Home Products Corporation Spray dried ibuprofen compositions
SE463541B (sv) * 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer produkt oeverdragen av en smaelta av sig sjaelv samt foerfarande foer dess framstaellning
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
IT1231410B (it) * 1987-09-22 1991-12-04 Cooperativa Farmaceutica Composizione farmaceutica antiinfiammatoria ad effetto prolungato per uso topico
US5068110A (en) * 1987-09-29 1991-11-26 Warner-Lambert Company Stabilization of enteric coated dosage form
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
US5160743A (en) * 1988-04-28 1992-11-03 Alza Corporation Annealed composition for pharmaceutically acceptable drug
US5006346A (en) * 1988-04-28 1991-04-09 Alza Corporation Delivery system
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
US5350741A (en) * 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
DE3838094A1 (de) * 1988-11-10 1990-05-17 Nordmark Arzneimittel Gmbh Feste pharmazeutische retardform
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
DK161743C (da) * 1989-07-03 1992-02-17 Niro Atomizer As Fremgangsmaade og apparat til agglomerering af et pulverformigt materiale
US5013557A (en) * 1989-10-03 1991-05-07 Warner-Lambert Company Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same
CA2100272A1 (en) * 1991-01-03 1992-07-04 Thomas Patrick Molloy Method for production of solid pharmaceutical preparation
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
RU2120798C1 (ru) * 1991-11-22 1998-10-27 Проктер энд Гэмбл Фармасьютикалз, Инк. Твердая фармацевтическая композиция для перорального введения
US5681585A (en) 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
DE69332801T2 (de) * 1992-11-30 2004-01-29 Kv Pharm Co Geschmacksmaskierte pharmazeutische substanzen
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
US6210714B1 (en) 1993-11-23 2001-04-03 Euro-Celtique S.A. Immediate release tablet cores of acetaminophen having sustained-release coating
US5500227A (en) * 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.
US5938990A (en) * 1994-07-01 1999-08-17 Roche Vitamins Inc. Encapsulation of oleophilic substances and compositions produced thereby
ES2316333T3 (es) * 1994-07-08 2009-04-16 Astrazeneca Ab Forma de dosificacion en tabletas constituida por unidades multiples.
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
US5744164A (en) * 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
US5683718A (en) * 1995-04-04 1997-11-04 Time-Cap Labs, Inc. Enteric coated tablet with raised identification character and method of manufacture
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
WO1997000674A1 (en) * 1995-06-20 1997-01-09 Pharma-Vinci A/S A method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method
US6123797A (en) * 1995-06-23 2000-09-26 The Dow Chemical Company Method for coating a non-wetting fluidizable and material onto a substrate
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
US6484879B2 (en) 1997-04-07 2002-11-26 Syngenta Crop Protection, Inc. Water soluble packaging system and method
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US5851579A (en) * 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions
WO1999001111A1 (en) 1997-07-02 1999-01-14 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
SI9700186B (sl) 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US6296876B1 (en) 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
US6096340A (en) 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6245357B1 (en) * 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
US8524277B2 (en) 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096341A (en) * 1998-10-30 2000-08-01 Pharma Pass Llc Delayed release tablet of bupropion hydrochloride
US6033686A (en) * 1998-10-30 2000-03-07 Pharma Pass Llc Controlled release tablet of bupropion hydrochloride
KR100299562B1 (ko) 1998-12-29 2001-11-22 우재영 안정성을극대화시킨5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸유도체함유미세과립
DE19901687B4 (de) * 1999-01-18 2006-06-01 Grünenthal GmbH Opioide Analgetika mit kontrollierter Wirkstofffreisetzung
DK1183014T3 (da) 1999-06-14 2004-02-09 Cosmo Spa Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
EP1244429A1 (en) * 1999-12-16 2002-10-02 Eurand America, Incorporated Controlled release kci tablet formulations
US6627223B2 (en) 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US20030133982A1 (en) * 2001-12-20 2003-07-17 Heimlich John M. Zero-order sustained release dosage forms and method of making same
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
ES2316791T3 (es) * 2002-05-06 2009-04-16 Massachusetts Institute Of Technology Forma de dosificacion controlada por difusion y metodo de fabricacion inclusive impresion tridimensional.
US9107804B2 (en) * 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
CA2520321A1 (en) * 2003-04-04 2004-10-14 Pharmacia Corporation Oral extended release compressed tablets of multiparticulates
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US7632521B2 (en) 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
KR101038403B1 (ko) * 2004-07-28 2011-06-01 다이닛본 스미토모 세이야꾸 가부시끼가이샤 복수의 층을 갖는 필름-코팅된 정제
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060182806A1 (en) * 2004-11-08 2006-08-17 Mintong Guo Extended-release propranolol composition
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20070087056A1 (en) * 2005-08-09 2007-04-19 Claudia Guthmann Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CN104825397A (zh) 2006-04-03 2015-08-12 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US20080131467A1 (en) * 2006-11-30 2008-06-05 Dennis Nelson Film-coated solid dosage form
US20100136110A1 (en) * 2008-09-30 2010-06-03 Astellas Pharma Inc. Granular pharmaceutical composition for oral administration
AU2010325746B2 (en) 2009-12-02 2016-02-25 Adare Pharmaceuticals S.R.L. Fexofenadine microcapsules and compositions containing them
TWI398274B (zh) * 2009-12-21 2013-06-11 Tci Co Ltd Oral tablets
US20140030349A1 (en) * 2011-04-18 2014-01-30 Idemitsu Kosan Co., Ltd. Granules in liquid dosage form
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
CN106924206A (zh) * 2015-12-31 2017-07-07 深圳翰宇药业股份有限公司 一种依格列净口服固体制剂及其制备方法
CN108451922A (zh) * 2018-05-03 2018-08-28 汤臣倍健股份有限公司 一种软胶囊防粘连工艺
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL109170C (da) * 1958-02-03
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
DE1204363B (de) * 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
FR1396710A (fr) * 1964-06-15 1965-04-23 Diwag Chemische Fabriken G M B Procédé pour la fabrication de charges ou supports perfectionnés et produits obtenus
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
US4178361A (en) * 1973-09-10 1979-12-11 Union Corporation Sustained release pharmaceutical composition
JPS517116A (en) * 1974-06-11 1976-01-21 Shinetsu Chemical Co Choyoseihifukuyakuzaino seizohoho
GB1576376A (en) 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
JPS53139715A (en) * 1977-05-11 1978-12-06 Shin Etsu Chem Co Ltd Method of coating solid medicine
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
SE7813246L (sv) 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4259315A (en) * 1980-06-13 1981-03-31 A. H. Robins Company, Inc. Controlled release potassium dosage form
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DE3233764A1 (de) * 1982-09-11 1984-03-15 R.P. Scherer GmbH, 6930 Eberbach Verfahren zur herstellung oraler dosierungseinheiten
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
SE8404467D0 (sv) * 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations

Also Published As

Publication number Publication date
DK158032B (da) 1990-03-19
EP0153105A2 (en) 1985-08-28
DK462685D0 (da) 1985-10-09
IE850307L (en) 1985-08-10
DK462685A (da) 1985-10-09
AU571312B2 (en) 1988-04-14
DE3586600D1 (de) 1992-10-15
AU3935985A (en) 1985-08-27
CA1247009A (en) 1988-12-20
IE59287B1 (en) 1994-02-09
JPH0759499B2 (ja) 1995-06-28
JPS61501150A (ja) 1986-06-12
DE3586600T2 (de) 1993-02-18
EP0153105B1 (en) 1992-09-09
HK1000201A1 (en) 1998-02-06
WO1985003436A1 (en) 1985-08-15
US4716041A (en) 1987-12-29
EP0153105A3 (en) 1985-12-18

Similar Documents

Publication Publication Date Title
DK158032C (da) Polydepotpraeparat med kontrolleret afgivelse af aktivt stof og fremgangsmaade til fremstilling af dette polydepotpraeparat
DK495585D0 (da) Farmaceutisk praeparat med kontrolleret frigivelse og fremgangsmaade til fremstilling af samme
DK162385D0 (da) Implanterbare praeparater af regulatoriske peptider med styret frigoerelse og fremgangsmaade til fremstilling heraf
DK616986D0 (da) Saarplejemiddel indeholdende et aktivt stof til fremme af saarbehandlingen og fremgangsmaade til fremstilling deraf
DK494782A (da) Kapsel med langvarig frigoerelse af aktivt stof til droevtyggere
DK287687D0 (da) Nyt laegemiddelpraeparat med kontrolleret frigivelse af den virksomme forbindelse, fremgangsmaade til fremstilling deraf og anvendelse af det nye praeparat
DK3880A (da) Fremgangsmaade til fremstilling af peptidylargininaldehydderivater og disses anvendelse
DK9888D0 (da) Kombinationer med synerigstisk virkning paa frigoerelsen af vaeksthormon og fremgangsmaader til deres anvendelse
DK324385A (da) Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof
DK272383A (da) Farmaceutisk blandingspraeparat med kontrolleret frigivelse af aktivt stof indbefattet maskering af daarlig smag og foroegelse af det aktive stofs stabilitet
DK367786D0 (da) Praeparat og fremgangsmaade til bevaring af planter og plantedele
DK559387A (da) Fremgangsmaade og mellemprodukt til fremstilling af 3-pyrrolidinoler
DK106685D0 (da) Kontrolleret afgivelse af virksomt stof samt fremgangsmaade til fremstilling deraf
DK379380A (da) Fremgangsmaade til fremstilling af 1-aminocyclopropan-carbolsyre og derivater deraf
DK350883D0 (da) Fremgangsmade til fremstilling af mycaminosyltylonolid og beslaegtede macrolidderivater og mellemprodukter herved
DK375987D0 (da) Fremgangsmaade til fremstilling af cycloalkyl-sub-stituerede 4-pyridyl derivater
DK549087A (da) Gangliosidbeslaegtede forbindelser og fremgangsmaade til fremstilling af samme
DK448887A (da) Hidtil ukendt amylaseenzym og fremgangsmaade til fremstilling af samme
DK38493D0 (da) Fremgangsmaade til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
DK436887A (da) Fremgangsmaade til fremstilling af triazol-tetrahydrofuran-derivater og mellemprodukter til anvendelse herved
DK464686A (da) Praeparat med kontrolleret afgivelse af det aktive stof
DK241882A (da) Fremgangsmaade til fremstilling af amider med antihypertensiv og angiotensinomdannende enzymhaemmende virkning
DK617187D0 (da) Fremgangsmaade til fremstilling af tabeletter med clovoxamin-fumarat og de saaledes fremstillede tabletter
DK84183A (da) Benzyletherderivater af pentiter og fremgangsmaade til fremstilling deraf
DK465886D0 (da) Formular til behandling af patentansaegning og fremgangsmaade til fremstilling af samme

Legal Events

Date Code Title Description
PUP Patent expired